Nd-Z-L-ornithine methyl ester hydrochloride, 99.0%, 5g

2-((6,7-DIMETHOXYQUINAZOLIN-4-YL)THIO)-5-METHYL-1,3,4-THIADIAZOLE, 95.0%, 1g

Recipiente de cristalización ROTILABO® sin pico, 20 ml, 40 mm, 10 Unidad(es)

3-(Benzyloxy)-2-methyl-4H-pyran-4-one, 97.0%, 2g

Lithium Formate Monohydrate>98.0%(T)25g

(S)-TERT-BUTYL 2-(4-BROMOPHENYL)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 1g

Indolin-1-amine hydrochloride, 95.0%, 1g

1,2,4,5-Tetramethyl-1H-imidazole, 95%, 1g

1-METHYLAZEPANE-4-CARBOXYLIC ACID, 97.0%, 5g

n-Cyclopropylcyclohexanecarboxamide, 98%, 5g

N,N-Diethylpropionamide, 95.0%, 5g

6-Bromo-2,3-difluorobenzotrifluoride, 98.0%, 25g

Peine ROTIPHORESE® PROfessional I, 2,0 mm, Bolsa, 2+2, 1 Pieza